Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-09-12

FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA supplemental approval granted for HUMULIN 70/30 (insulin human) by Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HUMULIN 70/30 (INSULIN HUMAN)

Snippet

SUPPL AP for HUMULIN 70/30 (INSULIN HUMAN)